Trifarotene: First Approval.
- Published in:
- Drugs, 2019, v. 79, n. 17, p. 1905, doi. 10.1007/s40265-019-01218-6
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2019 AND VI 79 AND IP 17
Results: 9
1
2
Dupilumab: A Review in Moderate to Severe Asthma.
- Published in:
- Drugs, 2019, v. 79, n. 17, p. 1885, doi. 10.1007/s40265-019-01221-x
- By:
- Publication type:
- Article
3
Correction to: Benefit:Risk Profile of Budesonide in Obstructive Airways Disease.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
4
Leave it to Lefamulin: A Pleuromutilin Treatment Option in Community-Acquired Bacterial Pneumonia.
- Published in:
- Drugs, 2019, v. 79, n. 17, p. 1867, doi. 10.1007/s40265-019-01219-5
- By:
- Publication type:
- Article
5
Tenapanor: First Approval.
- Published in:
- Drugs, 2019, v. 79, n. 17, p. 1897, doi. 10.1007/s40265-019-01215-9
- By:
- Publication type:
- Article
6
Dapagliflozin: A Review in Type 1 Diabetes.
- Published in:
- Drugs, 2019, v. 79, n. 17, p. 1877, doi. 10.1007/s40265-019-01213-x
- By:
- Publication type:
- Article
7
Fixed and Low-Dose Combinations of Blood Pressure-Lowering Agents: For the Many or the Few?
- Published in:
- Drugs, 2019, v. 79, n. 17, p. 1831, doi. 10.1007/s40265-019-01209-7
- By:
- Publication type:
- Article
8
Advances in Endocrine-Based Therapies for Estrogen Receptor-Positive Metastatic Breast Cancer.
- Published in:
- Drugs, 2019, v. 79, n. 17, p. 1849, doi. 10.1007/s40265-019-01208-8
- By:
- Publication type:
- Article
9
Immunotherapy Against Gliomas: is the Breakthrough Near?
- Published in:
- Drugs, 2019, v. 79, n. 17, p. 1839, doi. 10.1007/s40265-019-01203-z
- By:
- Publication type:
- Article